2.445
2.40%
-0.055
전일 마감가:
$2.50
열려 있는:
$2.48
하루 거래량:
404.75K
Relative Volume:
0.59
시가총액:
$174.66M
수익:
-
순이익/손실:
$-117.50M
주가수익비율:
-0.9551
EPS:
-2.56
순현금흐름:
$-114.31M
1주 성능:
-9.63%
1개월 성능:
-42.18%
6개월 성능:
-62.63%
1년 성능:
-3.56%
엔카르타 Stock (NKTX) Company Profile
명칭
Nkarta Inc
전화
(925) 407-1049
주소
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
NKTX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
NKTX | 2.445 | 174.66M | 0 | -117.50M | -114.31M | -2.56 |
VRTX | 450.91 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 749.43 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 589.59 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 246.94 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 106.93 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
엔카르타 Stock (NKTX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-10-09 | 개시 | Rodman & Renshaw | Buy |
2024-08-14 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2024-03-22 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
2022-12-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2022-10-10 | 개시 | Canaccord Genuity | Buy |
2022-07-28 | 개시 | Needham | Buy |
2022-07-18 | 개시 | SVB Leerink | Outperform |
2022-03-11 | 개시 | Raymond James | Outperform |
2022-03-08 | 개시 | H.C. Wainwright | Buy |
2022-01-06 | 개시 | William Blair | Outperform |
2021-11-18 | 개시 | SMBC Nikko | Outperform |
2021-07-16 | 개시 | Oppenheimer | Outperform |
2020-08-04 | 개시 | Cowen | Outperform |
2020-08-04 | 개시 | Evercore ISI | Outperform |
2020-08-04 | 개시 | Mizuho | Buy |
2020-08-04 | 개시 | Stifel | Buy |
모두보기
엔카르타 주식(NKTX)의 최신 뉴스
Nkarta price target lowered to $16 from $20 at Mizuho - TipRanks
NKTX stock touches 52-week low at $2.44 amid market fluctuations - Investing.com UK
Despite Hitting US$2.91, Nkarta Insiders Still Sold Too Soon - Simply Wall St
Q3 Biotech Earnings Recap: Nkarta, Intellia, Cassava and more - BioSpace
Nkarta to Participate in an Upcoming Investor Conference - The Manila Times
Nkarta to Present at Stifel Healthcare Conference: NK Cell Therapy Updates Expected | NKTX Stock News - StockTitan
Nkarta (NASDAQ:NKTX) Price Target Cut to $18.00 by Analysts at HC Wainwright - MarketBeat
Nkarta (NASDAQ:NKTX) Given New $11.00 Price Target at Needham & Company LLC - MarketBeat
Nkarta, Inc. Reports Q3 2024 Financial Results - TipRanks
Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights - GlobeNewswire
Nkarta, Inc. (NASDAQ:NKTX) Receives $17.50 Average PT from Brokerages - Defense World
Brokerages Set Nkarta, Inc. (NASDAQ:NKTX) Price Target at $17.50 - MarketBeat
Nkarta (NKTX) Stock: Looking For Upside - Seeking Alpha
Nkarta: Catalysts Ahead, But Competition In Cell Therapy Too (Rating Downgrade) - Seeking Alpha
SG Americas Securities LLC Purchases New Shares in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Bleakley Financial Group LLC Has $69,000 Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Companies Like Nkarta (NASDAQ:NKTX) Are In A Position To Invest In Growth - Yahoo Finance
GAMMA Investing LLC Increases Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Are Nkarta Inc (NKTX) shares a good deal now? - US Post News
Daily Market Movement: Nkarta Inc (NKTX) Sees a 1.29 Increase, Closing at 3.94 - The Dwinnex
Nkarta, Inc. (NASDAQ:NKTX) Shares Bought by Dimensional Fund Advisors LP - Defense World
AQR Capital Management LLC Invests $938,000 in Nkarta, Inc. (NASDAQ:NKTX) - MarketBeat
Nkarta Inc (NKTX) Stock: A Year of Market Fluctuations - The InvestChronicle
Nkarta (NASDAQ:NKTX) Stock Rating Upgraded by RODMAN&RENSHAW - Defense World
Nkarta (NASDAQ:NKTX) Upgraded to "Strong-Buy" by RODMAN&RENSHAW - MarketBeat
Nkarta, Inc. (NASDAQ:NKTX) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Nkarta (NASDAQ:NKTX) Coverage Initiated by Analysts at Rodman & Renshaw - MarketBeat
Raymond James upgrades Nkarta Inc (NKTX) stock to a Strong buy - Knox Daily
Nkarta upgraded at Raymond James on valuation - MSN
A History of Outperforming Analyst Forecasts and Beating the Odds: Nkarta Inc (NKTX) - SETE News
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month - Benzinga
Metric Analysis: Nkarta Inc (NKTX)’s Key Ratios in the Limelight - The Dwinnex
Nkarta Inc (NKTX) stock on the rise: An overview - US Post News
American Century Companies Inc. Has $427,000 Stake in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Anchoring Your Portfolio: Is NKTX Stock a Safe Harbor? - The InvestChronicle
Marshall Wace LLP Grows Stake in Nkarta, Inc. (NASDAQ:NKTX) - MarketBeat
Nkarta, Inc. (NASDAQ:NKTX) Shares Bought by Marshall Wace LLP - Defense World
It makes sense and dollars to buy Nkarta Inc (NKTX) stock - SETE News
Cubist Systematic Strategies LLC Invests $1.49 Million in Nkarta, Inc. (NASDAQ:NKTX) - MarketBeat
Nkarta Inc (NKTX) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
Nkarta's SWOT analysis: NK cell therapy stock shows promise amid risks - Investing.com India
Forefront Analytics LLC Invests $70,000 in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Renaissance Technologies LLC Acquires 98,000 Shares of Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Nkarta Inc [NASDAQ: NKTX] Sees Decrease in Stock Value - Knox Daily
Nkarta, Inc. (NASDAQ:NKTX) Shares Sold by Deerfield Management Company L.P. Series C - MarketBeat
Rhumbline Advisers Acquires 33,117 Shares of Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Affinity Asset Advisors LLC Purchases New Shares in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Affinity Asset Advisors LLC Takes Position in Nkarta, Inc. (NASDAQ:NKTX) - MarketBeat
Wall Street analysts’ outlook for Nkarta Inc (NKTX) - SETE News
Nkarta Inc (NKTX)’s highs and lows: A closer look at its stock price fluctuations - US Post News
Market Momentum Report: Nkarta Inc (NKTX)’s Negative Close at 5.21 - The Dwinnex
엔카르타 (NKTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
엔카르타 주식 (NKTX) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Trager James | Chief Scientific Officer |
Jun 18 '24 |
Sale |
5.60 |
456 |
2,554 |
150,959 |
HASTINGS PAUL J | Chief Executive Officer |
Jun 18 '24 |
Sale |
5.60 |
1,770 |
9,912 |
240,737 |
Shook David | Chief Medical Officer |
Jun 18 '24 |
Sale |
5.60 |
456 |
2,554 |
116,524 |
Hager Alicia J. | Chief Legal Officer |
Jun 18 '24 |
Sale |
5.60 |
727 |
4,071 |
107,215 |
Brandenberger Ralph | Chief Technical Officer |
Jun 18 '24 |
Sale |
5.60 |
229 |
1,282 |
79,743 |
RA CAPITAL MANAGEMENT, L.P. | Director |
Mar 27 '24 |
Buy |
10.00 |
3,000,000 |
30,000,000 |
10,050,818 |
George Simeon | Director |
Mar 27 '24 |
Buy |
10.00 |
2,000,000 |
20,000,000 |
1,548,341 |
Brandenberger Ralph | Chief Technical Officer |
Mar 01 '24 |
Option Exercise |
3.89 |
6,763 |
26,308 |
88,339 |
Brandenberger Ralph | Chief Technical Officer |
Mar 01 '24 |
Sale |
12.51 |
8,367 |
104,671 |
79,972 |
Trager James | Chief Scientific Officer |
Feb 12 '24 |
Sale |
12.00 |
4,143 |
49,716 |
149,415 |
자본화:
|
볼륨(24시간):